| 1 |
receptor activator of NF-kappaB ligand
(4486 times)
|
Biochemistry
(507 times)
|
OPG (1487 times)
TRAP (513 times)
M-CSF (377 times)
|
1998 Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells.
|
| 2 |
RANK ligand
(336 times)
|
Neoplasms
(54 times)
|
RANK (195 times)
OPG (150 times)
TRAP (20 times)
|
1997 A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
|
| 3 |
RANK and its ligand
(6 times)
|
Medicine
(1 time)
|
OPG (2 times)
RANK (2 times)
AIRE (1 time)
|
2006 Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization.
|
| 4 |
RANK-RANK ligand
(5 times)
|
Metabolism
(2 times)
|
RANK (2 times)
AZURE (1 time)
fRANK (1 time)
|
2011 Clinical development of anti-RANKL therapies for treatment and prevention of bone metastasis.
|
| 5 |
anti-RANK ligand
(3 times)
|
Endocrinology
(1 time)
|
GHD (1 time)
NAFLD (1 time)
NASH (1 time)
|
2015 Efficacy and safety of denosumab for the treatment of osteoporosis: A systematic review.
|
| 6 |
osteoclastogenesis-related cytokines
(2 times)
|
Dentistry
(2 times)
|
IL (1 time)
miR-146a (1 time)
muCT (1 time)
|
2016 Could cytokine levels in the peri-implant crevicular fluid be used to distinguish between healthy implants and implants with peri-implantitis? A systematic review.
|
| 7 |
receptor of NF-kappaB ligand
(2 times)
|
Dentistry
(1 time)
|
BRONJ (1 time)
MMP-9 (1 time)
n-bis (1 time)
|
2011 Matrix metalloproteinase-9 expression in alveolar extraction sockets of Zoledronic acid-treated rats.
|
| 8 |
regulating nuclear factor kappa-Beta ligand
(2 times)
|
Antineoplastic Agents
(2 times)
|
PACs (2 times)
|
2019 Proanthocyanidins attenuate breast cancer-induced bone metastasis by inhibiting Irf-3/c-jun activation.
|
| 9 |
RANK and its ligand TRANCE
(1 time)
|
Allergy and Immunology
(1 time)
|
htSNPs (1 time)
T1D (1 time)
TDT (1 time)
|
2004 Cost-effective analysis of candidate genes using htSNPs: a staged approach.
|
| 10 |
RANK binding ligand
(1 time)
|
Medicine
(1 time)
|
RANK (1 time)
|
2019 Is vitamin D deficiency behind the scenes for high incidence of Giant cell tumor amongst the Indian population? Unraveling the vitamin D - RANKL association.
|
| 11 |
RANKL Tg
(1 time)
|
Metabolism
(1 time)
|
BMMPhis (1 time)
DPH (1 time)
LPS (1 time)
|
2009 Diphenylhydantoin inhibits osteoclast differentiation and function through suppression of NFATc1 signaling.
|
| 12 |
RANKL, TRANCE, ODF
(1 time)
|
Rheumatology
(1 time)
|
---
|
2002 Role of RANKL and RANK in bone loss and arthritis.
|
| 13 |
RANKL-overexpressing LNCaP PCa cell line, LNCaP
(1 time)
|
Neoplasms
(1 time)
|
PCa (1 time)
|
2014 Induction of integrin alpha2 in a highly bone metastatic human prostate cancer cell line: roles of RANKL and AR under three-dimensional suspension culture.
|
| 14 |
ratio of NF-kappaB ligand
(1 time)
|
Histocytochemistry
(1 time)
|
BMP2 (1 time)
CDK2 (1 time)
OPG (1 time)
|
2016 CBX7 deficiency plays a positive role in dentin and alveolar bone development.
|
| 15 |
Receptor Activator of Nuclear factor Kappa B Receptor
(1 time)
|
Medicine
(1 time)
|
hMSCs (1 time)
|
2015 Impact of the uremic milieu on the osteogenic potential of mesenchymal stem cells.
|
| 16 |
receptor activator of nuclear factor kappaB ligand to osteoprotegerin
(1 time)
|
Rheumatology
(1 time)
|
M-CSF (1 time)
|
2008 Imbalanced expression of RANKL and osteoprotegerin mRNA in pannus tissue of rheumatoid arthritis.
|
| 17 |
receptor activator of nuclear factor small ka, CyrillicB ligand
(1 time)
|
Dentistry
(1 time)
|
ALP (1 time)
OPG (1 time)
|
2008 Cementoblast response to low- and high-intensity ultrasound.
|
| 18 |
receptor activator of nuclear transcription factor-kappaB
(1 time)
|
Metabolism
(1 time)
|
MIP (1 time)
VEGF (1 time)
|
2002 Role of the bone marrow microenvironment in multiple myeloma.
|
| 19 |
receptor of activator of NF(Kappa)B ligand receptor
(1 time)
|
Medicine
(1 time)
|
BAP (1 time)
BMD (1 time)
OPG (1 time)
|
2006 Receptor activator of NF(Kappa)B ligand/osteoprotegerin (RANKL/OPG) system and osteopontin (OPN) serum levels in a population of apulian postmenopausal women.
|
| 20 |
receptor of nuclear factor kB
(1 time)
|
Neoplasms
(1 time)
|
OC (1 time)
|
2010 Serum bone turnover markers may be involved in the metastatic potential of lung cancer patients.
|
| 21 |
receptor-activated nuclear factor kappa B ligand expression
(1 time)
|
Nutritional Sciences
(1 time)
|
Cd (1 time)
OPG (1 time)
|
2013 Environmental level of cadmium exposure stimulates osteoclasts formation in male rats.
|
| 22 |
results of several kinds of knockout mice, osteoclast differentiation factor
(1 time)
|
Metabolism
(1 time)
|
---
|
2011 [Osteoporosis and RANKL signal].
|
| 23 |
rhIL-1alpha-induced PGE2 increased the expression of nuclear factor kappaB ligand
(1 time)
|
Dentistry
(1 time)
|
IL-1alpha (1 time)
M-CSF (1 time)
MMPs (1 time)
|
2005 Effects of positive pressure in odontogenic keratocysts.
|
| 24 |
sclerostin and nuclear factor κB ligand
(1 time)
|
Medicine
(1 time)
|
---
|
2020 Importance of osteocyte-mediated regulation of bone remodelling in inflammatory bone disease.
|
| 25 |
up-regulated, while the nuclear factor-kappaB ligand
(1 time)
|
Biology
(1 time)
|
Col1a1 (1 time)
M-CSF (1 time)
OPG (1 time)
|
2018 Tetrahydroxystilbene Glucoside Regulates Proliferation, Differentiation, and OPG/RANKL/M-CSF Expression in MC3T3-E1 Cells via the PI3K/Akt Pathway.
|
A Search Service for Abbreviation / Long Form